drugset / Trial / NCT05238506

Lidocaine VS Hemodynamic, Metabolic and Hormonal Response

NCT05238506 ↗

Phase 4 Completed 132 enrolled Medical University of Warsaw
RandomizedParallel-groupQuadruple-blindSupportive care

Summary

Intravenous lidocaine - a potent local anesthetic with analgesic and anti- inflammatory properties has been shown to be an effective adjunct that reduces intra and postoperative opioid consumption and facilitates pain management in adults. In children population promising but limited evidence is available. The study has been planned to evaluate the efficacy of continuous intravenous infusion of lidocaine in alleviation of hemodynamic reaction to tracheal intubation, as well as metabolic and hormonal response to laparoscopic procedure in children.

Timeline

Start
2022-03-12
Primary completion
2023-08-08
Completion
2023-08-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 1.5 mg/kg Intravenous

Indications